theory clinical_35_1
imports Main

begin

typedecl entity
typedecl event

consts
  NotchInhibitor :: "entity ⇒ bool"
  BetaCatenin :: "entity ⇒ bool"
  Decrease :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  CTNNB1Mutation :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Development :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Reducing :: "event ⇒ bool"
  Counteract :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  Effective :: "entity ⇒ bool"
  Treating :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Notch inhibitors decrease the level of β-catenin. *)
axiomatization where
  explanation_1: "∃x y e. NotchInhibitor x ∧ BetaCatenin y ∧ Decrease e ∧ Agent e x ∧ Patient e y"

(* Explanation 2: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_2: "∃x y z e. CTNNB1Mutation x ∧ Proliferation y ∧ Cell z ∧ BetaCatenin z ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via e z"

(* Explanation 3: There are Notch inhibitors in development. *)
axiomatization where
  explanation_3: "∃x y. NotchInhibitor x ∧ Development y ∧ In x y"

(* Explanation 4: Reducing the level of β-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB. *)
axiomatization where
  explanation_4: "∃x y z e1 e2. BetaCatenin x ∧ Proliferation y ∧ Cell z ∧ CTNNB1Mutation z ∧ Reducing e1 ∧ Agent e1 x ∧ Counteract e2 ∧ Agent e2 z ∧ Patient e2 y ∧ Cause e2 z"

theorem hypothesis:
  assumes asm: "NotchInhibitor x ∧ CTNNB1Mutation y ∧ Patient e y"
  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
  shows "∃x y. NotchInhibitor x ∧ Effective x ∧ Patient e y ∧ CTNNB1Mutation y ∧ Treating x y"
proof -
  (* From the premise, we have known information about Notch inhibitors and CTNNB1 mutations. *)
  from asm have "NotchInhibitor x ∧ CTNNB1Mutation y ∧ Patient e y" by simp
  (* Explanation 1 states that Notch inhibitors decrease the level of β-catenin. *)
  (* Explanation 4 states that reducing the level of β-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)
  (* There is a logical relation Implies(A, D), Implies(Notch inhibitors decrease the level of β-catenin, Reducing the level of β-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1). *)
  (* From this, we can infer that Notch inhibitors can counteract the proliferation of cells caused by CTNNB1 mutations. *)
  then have "NotchInhibitor x ∧ Effective x ∧ Patient e y ∧ CTNNB1Mutation y" sledgehammer
  (* Since Notch inhibitors can counteract the proliferation, they may be effective in treating patients with CTNNB1 mutations. *)
  then show ?thesis <ATP>
qed

end
